Terra Innovatum Global N.V. Ordinary shares
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NKLR research report →
Range $8 – $8
Price Chart
About the company
Terra Innovatum Global N. V. , a nuclear energy technology company, develops micro-modular nuclear reactors to deliver power solutions.
- CEO
- Alessandro Petruzzi
- IPO
- 2025
- Employees
- 5
- HQ
- Lucca, LU, IT
Get TickerSpark's AI analysis on NKLR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $222.11M
- P/E
- 0.34
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 0.20
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -755.07%
- ROIC
- -55.69%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-33,699,000
- Net Income
- $539.52M+1586935.3%
- EPS
- $9.74+0.0%
- OCF Growth
- -11192491.3%
- FCF Growth
- -11959870.1%
- 52W High
- $7.93
- 52W Low
- $1.74
- 50D MA
- $2.93
- 200D MA
- $4.67
- Beta
- 1.55
- RSI (14)
- 41
- Avg Volume
- 414.52K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Terra Innovatum said it is shifting from preparation to execution on its first SOLO reactor, while keeping licensing, procurement, and customer conversion on track toward a 2027 FOAK deployment and 2028 commercialization target.· November 18, 2026
- Q3 net income was $61 million, driven by a $67.5 million noncash gain from settled contingent warrant liabilities.
- Cash and cash equivalents fell to $82.4 million from $91.1 million at June 30, while operating expenses were $7.1 million.
- Management said it has begun procurement on major reactor components and completed sharing all 18 draft PSAR chapters with the NRC for readiness review.
- The company still targets first-of-a-kind reactor deployment in 2027, with commercial deployments beginning in 2028, subject to approvals and execution.
- Management says commercial work is moving from LOIs/MOUs toward framework agreements that could include 25% to 30% customer down payments.
Terra Innovatum reported $61 million in net income for Q3 2026, or $0.55 per basic and diluted share. That included $67.5 million of noncash gains from changes in the fair value of settled contingent warrant liabilities. Total operating expenses were $7.1 million, including $1.7 million of development costs and $5.4 million of general and administrative expenses. Cash and cash equivalents ended September 30, 2026 at $82.4 million, down from $91.1 million at June 30, 2026, and advances to suppliers totaled $2.6 million. Management said the company has spent about one-third of the $70 million first-of-a-kind budget and expects to stay on budget, with $20 million to $30 million remaining for commercialization efforts; regulatory cost within that budget is about $15 million. Expected 2027 cash burn is between $30 million and $35 million. The company reiterated its target of first-of-a-kind deployment in 2027 and commercial deployments beginning in 2028.
Alessandro Petruzzi framed the quarter as a transition from planning to execution, emphasizing equipment procurement, manufacturing preparation, NRC readiness work, and customer pipeline development. He repeatedly said the company is still on its original roadmap and believes its off-the-shelf supply chain keeps costs in line with earlier estimates. His tone was confident and constructive, but he also stressed that execution on the first reactor and customer conversion are the key milestones that will prove the business model.
Katherine Williams highlighted the balance sheet and spend discipline, saying Terra ended Q3 with $82.4 million in cash and cash equivalents and had $2.6 million of supplier advances. She said Q3 operating expenses were $7.1 million and reiterated that the company is managing capital against licensing, engineering, procurement, and manufacturing readiness. She also quantified the first-of-a-kind plan: about one-third of the $70 million budget has been spent, the company expects to stay on budget, regulatory cost is budgeted at around $15 million, and 2027 cash burn should be between $30 million and $35 million.
Analysts focused on NRC timing, supplier readiness, the remaining pieces of the supply chain, and when customers might move from nonbinding LOIs/MOUs to binding orders. Management said it has continuous contact with the NRC, with meetings two to three times per week, and expects readiness review feedback in the coming weeks; it also said there is no evidence yet of a delay. On commercialization, management said it is working toward framework agreements with clearer timelines, pricing, and delivery protections, and discussed expected customer down payments of 25% to 30% of reactor cost. Management also said fuel procurement is being finalized, EPC/site work has started at Rock City, and it is considering both Part 50 and a future Part 57 path.
The positive case is that Terra says it is now spending real capital on the first reactor while keeping the project on budget and on schedule. Management also believes the NRC process is progressing, the supply chain is largely secured, and customer discussions are becoming more concrete as the company moves toward framework agreements and potential deposits. If the first-of-a-kind site comes together as planned, management thinks that could be a meaningful proof point for future commercial orders.
The main risks remain execution and regulatory timing: the company still needs to complete readiness review, submit the construction permit application, and secure remaining major equipment and fuel. Commercial demand is still mostly nonbinding, and management acknowledged that customers need confidence before signing binding orders. The business also remains dependent on a successful first-of-a-kind deployment, and management said commercialization hinges on proving the product and the delivery timeline in the face of government-regulated nuclear permitting.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 30.9%
- Shares Outstanding
- 110.50M
- Float Shares
- 34.17M
of shares held by institutions
51 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Segra Capital Management, LLC | 2.88M | ▲ 262.85K |
| Mirae Asset Global Etfs Holdings Ltd. | 1.48M | ▲ 1.48M |
| Magnetar Financial LLC | 761.60K | ▼ 4.00K |
| Exchange Traded Concepts, LLC | 508.09K | ▼ 2.84M |
| Jane Street Group, LLC | 461.95K | ▲ 177.96K |
| Cerity Partners LLC | 352.83K | ▲ 91.63K |
| Ubs Group AG | 291.15K | ▲ 119.73K |
| Goldman Sachs Group Inc | 283.09K | ▲ 265.24K |
| Linden Advisors LP | 212.94K | ▲ 41.41K |
| Marshall Wace, Llp | 204.17K | ▲ 186.28K |
| Hudson Bay Capital Management LP | 167.32K | ▼ 18.58K |
| Lmr Partners Llp | 166.63K | 0 |
Held by 22 ETFs
Biggest fund positions in NKLR by dollar value.
Our NKLR coverage
Recent articles, reports, and earnings notes.
Want a deeper read on NKLR?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Terra Innovatum Global N.V. (NKLR) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 18
What Terra Innovatum Global S.R.L. (NKLR) Said on Its Q3 Earnings Call
marketbeat.com · Nov 18
Terra Innovatum Reports Third Quarter 2026 Financial Results and Continued Progress Toward First Solo™ Reactor Deployment
globenewswire.com · Nov 16
Terra Innovatum to Provide Third Quarter 2026 Business and Financial Update on Monday, November 16
globenewswire.com · Nov 12
Terra Innovatum Achieves Key NRC Licensing Milestone, Delivers All 18 SOLO™ PSAR Chapters for Readiness Review as it Advances Toward 2027 First Reactor Deployment
globenewswire.com · Nov 4
Terra Innovatum Advances SOLO™ Construction Permit Application and Reactor Procurement, Reaffirms Fully Funded Path to 2027 First-Of-A-Kind Deployment
globenewswire.com · Oct 22
Terra Innovatum Advances Solo™ Industrial Manufacturing Program With ATB and Boldrocchi
globenewswire.com · Oct 14
Terra Innovatum Announces Upcoming Investor Conference Schedule
globenewswire.com · Sep 30
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
